Cross- Wellcome Africa Asian Programmes (AAPs) Acceleration of Genomics for Escalating infectious Diseases, (CAGED) Consortium
2
Issued Date
2026-01-01
Resource Type
eISSN
2398502X
Scopus ID
2-s2.0-105042073750
Journal Title
Wellcome Open Research
Volume
11
Rights Holder(s)
SCOPUS
Bibliographic Citation
Wellcome Open Research Vol.11 (2026)
Suggested Citation
Kiyuka P.K., M. Batty E., Dubot-Pérès A., Pham Thanh D., Amulele A., Mushicha P., Cornick J., Makhado N., Sigal A., Shankar A., Le Van T., Isabella Ochola-Oyier L. Cross- Wellcome Africa Asian Programmes (AAPs) Acceleration of Genomics for Escalating infectious Diseases, (CAGED) Consortium. Wellcome Open Research Vol.11 (2026). doi:10.12688/wellcomeopenres.25620.2 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/117460
Title
Cross- Wellcome Africa Asian Programmes (AAPs) Acceleration of Genomics for Escalating infectious Diseases, (CAGED) Consortium
Author's Affiliation
Nuffield Department of Medicine
Faculty of Tropical Medicine, Mahidol University
Wellcome Trust Research Laboratories Nairobi
Universita di Corsica Pascal Paoli
Oxford University Clinical Research Unit
Africa Health Research Institute
Centre for Geographic Medicine Research
Mahosot Hospital, Lao
Malawi Liverpool Wellcome Programme
Faculty of Tropical Medicine, Mahidol University
Wellcome Trust Research Laboratories Nairobi
Universita di Corsica Pascal Paoli
Oxford University Clinical Research Unit
Africa Health Research Institute
Centre for Geographic Medicine Research
Mahosot Hospital, Lao
Malawi Liverpool Wellcome Programme
Corresponding Author(s)
Other Contributor(s)
Abstract
The Cross-Wellcome Africa Asian Programmes (AAPs) Acceleration of Genomics for Escalating Infectious Diseases (CAGED) Consortium is a collaboration among six institutions: the Africa Health Research Institute, the Center for Infectious Disease Research in Africa, the KEMRI-Wellcome Trust Research Programme, the Malawi Liverpool Wellcome Programme, the Mahidol Oxford Tropical Medicine Research Unit and the Oxford University Clinical Research Unit. The consortium focuses on studying pathogens posing major public health threats in Africa and Southeast Asia including chikungunya virus (CHIKV) dengue virus (DENV), multidrug-resistant (MDR) Klebsiella pneumoniae (Kpn), and drug-resistant Mycobacterium tuberculosis (Mtb) with climate change considered one of the several factors influencing the distribution, transmission or burden of some of these pathogens. In this paper, we outline the consortium goals, planned activities, discuss challenges and future directions. By leveraging cross-continent expertise, CAGED aims to unravel the molecular epidemiology of escalating infectious diseases of public health importance in Africa and Southeast Asia, and build sustainable local sequencing capacity, helping the region better prepare for future emerging infectious disease outbreaks.